S 527
Prescription Pricing for the People Act of 2025
Jurisdiction
US Congress
Session
119th Congress (2025-2026)
Last updated at
Jun 14, 2026, 7:57 AM
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Bill overview
This bill directs the Federal Trade Commission (FTC) to investigate the pharmaceutical supply chain, specifically focusing on the role of intermediaries like pharmacy benefit managers (PBMs). The FTC must analyze potential anticompetitive practices, such as price manipulation and steering patients, and provide Congress with policy recommendations to improve transparency, competition, and consumer benefits within the industry. The bill also requires the FTC to submit interim reports on its progress and final findings.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.